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ABSTRACT
The early cell divisions of Xenopus laevis and
other metazoan embryos occur in the presence of
constitutively high levels of the cell cycle regulator
cyclin E1. Upon completion of the 12th cell division,
a time at which many maternal proteins are down-
regulated by deadenylation and destabilization of
their encoding mRNAs, maternal cyclin E1 protein is
downregulated while its mRNA is polyadenylated
and stable. We report here that stable polyadenyla-
tion of cyclin E1 mRNA requires three cis-acting
elements in the 30 untranslated region; the nuclear
polyadenylation sequence, a contiguous cytoplas-
mic polyadenylation element and an upstream
AU-rich element. ElrA, the Xenopus homolog of
HuR and a member of the ELAV gene family binds
the cyclin E1 30UTR with high affinity. Deletion
of these elements dramatically reduces the affinity
of ElrA for the cyclin E1 30UTR, abolishes poly-
adenylation and destabilizes the mRNA. Together,
these findings provide compelling evidence that
ElrA functions in polyadenylation and stabilization
of cyclin E1 mRNA via binding these elements.
INTRODUCTION
The ﬁrst 12 cleavage divisions in Xenopus laevis embryos
are rapid and occur in the absence of detectable RNA
synthesis. At the end of these divisions ( 7h post-
fertilization, hpf), the midblastula transition (MBT)
begins, characterized by the initiation of global zygotic
transcription and slowing of the cell cycle (1,2). Prior to
the MBT, synthesis and degradation of maternal cyclins,
whose mRNAs are transcribed and stored in the oocyte,
drive progression through the cell cycle. At the MBT,
several maternal cyclins are no longer synthesized,
resulting in remodeling of the embryonic cell cycle.
Cyclin E1 protein is distinct from other maternal cyclins
in that it is present at constitutively high levels during the
ﬁrst 12 cell cycles and is abruptly degraded at the MBT
(3–5). How high levels of cyclin E1 are maintained and
then abolished are largely unknown.
We have shown that translation of polyadenylated
cyclin E1 mRNA contributes to constitutively high pro-
tein levels before the MBT (6,7). At the MBT, cyclin E1
mRNA remains polyadenylated and stable, despite the
disappearance of cyclin E1 protein (3,5). This behavior
is in distinct contrast to that of cyclins A1 and B2, who
are synthesized and degraded during each cell cycle and
disappear after the MBT due to rapid deadenylation and
destabilization of their mRNAs (7,8). Their 30 untrans-
lated regions (30UTRs) specify the distinct behavior of
these maternal cyclin mRNAs (7). In addition, RNA gel
mobility shift and UV-cross-link assays showed that
a protein of  36kDa from Xenopus embryo extracts
bound the cyclin E1 30UTR but not the 30UTR of cyclin
A1 or B1 (unpublished). The purpose of the current study
is to identify this 36-kDa binding protein.
The cyclin E1 30UTR contains several U- and AU-rich
regions. These include an AU-rich element (ARE) of the
sequence U5AU5AU6A2 at position 1684, which is 45-nt
upstream of the nuclear polyadenylation sequence or
NPS (A2UA3), and a U15 contiguous with the NPS,
which ﬁts the deﬁnition of a cytoplasmic polyadenylation
element (CPE, 9). CPEs are U-rich sequences that specify
polyadenylation in Xenopus oocytes (maturation speciﬁc)
or embryos (embryonic speciﬁc) and require the NPS for
activity.
The 60-kDa CPE-binding protein (CPEB) binds
maturation-speciﬁc CPEs and is essential for cytoplas-
mic polyadenylation (10,11). The 36-kDa ElrA, a member
of the ELAV family of RNA-binding proteins, has been
shown to bind two mRNAs depending on the presence of
embryonic-speciﬁc CPEs, but a function in polyadenyla-
tion has not been shown (12). The majority of CPEB is
degraded at fertilization but ElrA is present at all times
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maturation-speciﬁc CPE tested, that of histone B4 (12).
HuR is the human homolog of ElrA and it binds AREs in
the 30UTRs of mRNAs to stabilize them (14). Since a 36-
kDa protein uniquely bound the cyclin E1 30UTR, we test
here whether it is ElrA. We show that ElrA binds the
30UTR of cyclin E1 mRNA in a manner depending on the
ARE and CPE that function in polyadenylation and
stabilization.
MATERIALS AND METHODS
Embryosand microinjections
Embryos were obtained and staged according to stand-
ard protocols and maintained in 0.1 Marc’s modiﬁed
Ringer’s medium at 238C (15,16). For mRNA micro-
injections, two-cell embryos were injected with
27.6nl of in vitro-transcribed capped mRNA in water
(100000c.p.m./ml). Embryo samples were collected at the
indicated time points. Total RNA from 5 embryos was
extracted with TRIzol (Invitrogen). Embryo protein
extracts were prepared as previously described (8).
30UTR constructs and in vitrotranscription
pGbA1 and pGbE1 were previously described (17).
pT7E1pA was constructed by ﬁrst generating the
cyclin E1 30UTR by amplifying nucleotides 1387–1784
(Genbank Accession Z13966) by PCR with primers E1-KF
ggggtacccAGTGCTTTAACTCTG-TGC and E1-BR
cgggatccAAAAA-AAACAGCTGTCTTCTAAACAGC.
The 50 and 30 primers contained a KpnI and BamHI site
(underlined), respectively. The resulting PCR product was
digested with KpnI and BamHI and inserted between
these sites in pGbORF/mosEDEN, which deleted the
EDEN sequence. pT7E1 was derived from the previously
described pGbE1 (7) by digesting with EcoRI and XbaI to
excise the globin ORF and recircularizing the plasmid.
pT7E1 was used to create cyclin E1 30UTR deletion
mutants. pT7E11575–1784 was constructed by deleting
the AvaI/EcoRV fragment and then recircularizing the
plasmid. pT7E11387–1571 was constructed by deleting
the XbaI/AvaI fragment from pT7E1 and recircularizing
the plasmid. Smaller deletions were made using the
Stratagene QuikChange mutagenesis protocol using pri-
mers (sense strand primers listed): pT7E11749–1754,
ATCTATCTTTTTTTTTTTTTTTGATGCTGTTTAGA
AGACAGC; pT7E1CPE (729-1754), GAATGCTGC
TACATATCGATGCT-GTTTAGAAG; pT7E1ARE/
CPE/NPS (1684-1754), CTGGCATGAGTGTTGCCG
ATGCTGTTTAGAAGACAGC; pT7E1AREþ/CPE
(1648-1748), CAGATGAGCTAATCAAAGTGCAAT
AAAGATGCTGTTTAGAAG; pT7E1ARE (1684-
1715), GAATCTGGCATGAGTGTTGCCTGCTGCTA
CATATCTATC. For in vitro transcription, pT7E11575-
1784 was linearized with Pvu II. All other plasmids
were linearized with EcoRV.
32P-labeled, capped mRNAs
were synthesized using T7 polymerase according to the
manufacturer’s recommendations (Promega).
GST-ElrA purification
GST-ElrA was puriﬁed using glutathione-sepharose beads
(GS) following the manufacturer’s protocol (Pharmacia).
Brieﬂy, a 300ml culture of E. coli dH5a, transformed
with pGEX-ElrA, was induced with 1 mM isopropyl-b-
D-thiogalactopyranoside for 3h at room temperature.
Bacteria were pelleted at 4000 g, resuspended in
lysis buﬀer, incubated on ice for 30min and then
brieﬂy sonicated. Lysed bacteria were centrifuged and
GST-ElrA was puriﬁed by incubation of the supernatant
with GS-beads. The amount of GST-ElrA obtained was
quantitated by Bradford assay. pGEX-ElrA was
previously described (12).
Gel shifts, UV-cross-link assays and determination ofKd
Gel shifts were done according to Westmark et al. (18).
Brieﬂy, 250ng of bacterially expressed GST-ElrA or
protein from one-ﬁfth of an embryo was incubated
with the indicated
32P-labeled RNA (4fmol) in gel shift
buﬀer (15mM HEPES pH 8, 10% glycerol, 10mM KCl,
1mM DTT, 1 unit/ml RNasin and 200ng tRNA) in a total
volume of 10ml for 15min at room temperature. Here,
20U of RNase T1 was added, and samples digested
for 20min at 378C. Samples were resolved on 6% native
polyacrylamide gels. Gels were ﬁxed, dried and visualized
by phosphorimaging. For gel shift competition assays,
unlabeled competitor RNA (cyclin A1 30UTR, Genbank
Accession P18606) was added along with the radiolabeled
RNA in the speciﬁed amounts. For Kd determinations,
gel shift assays were performed as described above except
that 1fmol of
32P-labeled RNA was incubated with
the indicated concentration of GST-ElrA for 15min and
then analyzed on native polyacrylamide gels (RNase T1
was not used). Free and bound RNA were quantiﬁed
using ImageQuant (Molecular Dynamics). Free RNA was
deﬁned as the position where the RNA migrated in the
absence of protein. UV-cross-link assays were done
similarly to gel shift assays except that following treatment
with RNase T1, samples were UV-cross-linked for 5min
on ice using a Stratalinker 1800 (Stratagene) and resolved
on a denaturing 10% SDS-PAG.
Immunoprecipitation
Five embryos injected with radiolabeled cyclin E1 30UTR
at the two cell stage (between 1.5 and 2hpf) were collected
at 2 and 6h post-injection (4 and 8hpf). Protein extracts
were prepared from embryos as previously described (8),
diluted to a ﬁnal volume of 500ml in IP buﬀer (15mM
HEPES pH 8, 10% glycerol, 10mM KCl, 1mM DTT,
200ng tRNA, 320U RNasin) and incubated 15min at
room temperature. Samples were then treated with 400U
of RNase T1 (20mlo f2 0 U / ml) for 30min at 378C and
UV-cross-linked for 5min on ice. Either anti-HuR (raised
against the human protein, Santa Cruz, 3A2), anti-ElrA
(raised against the Xenopus protein, Drs Peter Good and
Michael Sheets) or pre-immune serum was added and
samples were incubated at 48C for 1h. Next, 15mlo f
protein G plus agarose (Santa Cruz) was added and
samples were rotated at 48C for 1h. Four washes were
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10% glycerol, 10mM KCl, 1mM DTT, 200ng tRNA
and 1% NP-40). Protein G beads were resuspended
in SDS reducing buﬀer, heated to 958C for 5min, and
supernatants resolved on a 10% SDS-PAG. The gel was
ﬁxed, dried and visualized by phosphorimaging.
Poly(A) tail analysis
Total RNA was extracted from ﬁve embryos injected with
radiolabeled, capped RNAs and resolved by electrophor-
esis on 6% polyacrylamide/8M urea gels as described
previously (19). Gels were ﬁxed, dried and visualized by
phosphorimaging.
RESULTS
ElrA binds to the30UTR ofcyclin E1mRNA
UV-cross-link assays with protein extracts of embryos
either before (4h or stage 7) or after (8h or stage 9) the
MBT showed that the 36-kDa protein bound both before
and after the MBT (Figure 1A, lanes labeled 4 and 8).
Since ElrA is also present both before and after the MBT,
we asked if it can bind the cyclin E1 30UTR. To determine
if ElrA can bind to the cyclin E1 30UTR, we performed
UV-cross-link assays with GST-ElrA and a radiolabeled
mRNA consisting of only the cyclin E1 30UTR (E1).
When recombinant GST-ElrA was prepared, it eluted
as a doublet, with the upper band  62kDa and the
faster migrating band at  55kDa (Figure 1B). This faster
migrating band is most likely a C-terminal cleavage
product of the full-length GST-ElrA that lacks RRM3.
The UV-cross-link assay shown in Figure 1A demon-
strates that GST-ElrA bound the cyclin E1 30UTR.
In contrast, GST did not bind suggesting that ElrA
speciﬁcally targets the 30UTR.
To test if recombinant ElrA binds any AU-rich
sequence or speciﬁcally binds the cyclin E1 30UTR, we
performed a gel shift competition assay using the cyclin
A1 30UTR as competitor (Figure 1C). The cyclin A1
30UTR contains a maturation-speciﬁc CPE contiguous
with the NPS and two AREs of the consensus sequence
U2AU3AU2. GST-ElrA was incubated with rabiolabeled
cyclin E1 30UTR either with or without a poly(A)65 tail
(E1pA or E1) in the presence of increasing amounts
of competitor; either unlabeled E1pA, E1, or unlabeled
cyclin A1 30UTR (A1). Results were the same in the
presence or the absence of the poly(A) tail, so are shown
E1pA
0 0.5 1 5 0  10  M
E1pA A1
C
Figure 1. GST-ElrA binds the 30UTR of cyclin E1 mRNA. (A) UV-cross-link assay: radiolabeled cyclin E1 30UTR (E1) was incubated with GST-
ElrA, GST or 4 and 8h embryo extracts. E1 lane is the RNA without added protein or RNase T1. RNase T1 lane is E1 digested with this enzyme in
the absence of added protein. Molecular weight markers are indicated to the left of the phosphorimage in kDa. The arrow indicates a 36-kDa protein
that binds in embryo extracts. n¼5. (B) Comassie blue stained gel of puriﬁed GST-ElrA. Molecular weight markers are indicated to the left of the
gel in kDa. (C) Gel shift competition assay: GST-ElrA was incubated with radiolabeled cyclin E1 30UTR containing a poly(A)65 tail (E1pA) in the
presence of increasing molar excess (M) of either unlabeled E1pA or an unlabeled competitor RNA (A1, cyclin A1 30UTR). E1pA lane is the RNA
alone without added protein or RNase T1. Arrow indicates ElrA bound mRNA. Samples were electrophoresed on native gels and analyzed by
phosphorimaging; the digested unbound RNA running at the bottom of the gel is not shown. Experiment was also performed in the absence of
a poly(A)65 tail with identical results. n¼3. (D) Binding assay to determine the dissociation constant of GST-ElrA for the cyclin E1 30UTR.
Radiolabeled cyclin E1 30UTR (1 fmol) was incubated with GST-ElrA over a range of 0–50nM. Reactions were electrophoresed on native gels and
analyzed by phosphorimaging. The bracket shows bound RNA and the line shows free RNA (n¼4). The results of the binding assay were
quantitated to determine the dissociation constant (Kd,) shown in panel (E).
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E1pA eﬀectively competed oﬀ the majority of bound
32P-labeled E1pA, a ten molar excess of unlabeled cyclin
A1 30UTR (A1), was unable to compete for ElrA binding.
This data shows that ElrA bound speciﬁcally to the cyclin
E1 30UTR and in agreement with prior HuR studies
(20,21), its binding did not require a poly(A) tail,
suggesting that ElrA can bind prior to polyadenylation.
We next performed native gel shifts to determine the
aﬃnity of ElrA for the cyclin E1 30UTR (Figure 1D).
32P-labeled cyclin E1 30UTR was incubated with increas-
ing amounts of GST-ElrA over a range of 0–50nM.
Complex formation began with 0.1nM of GST-ElrA and
steadily increased, with complete binding occurring with
5nM. ElrA bound to the 30UTR of cyclin E1 with an
apparent Kd of 1nM (Figure 1E). Overall, these data show
that the cyclin E1 30UTR is bound by ElrA with high
aﬃnity in vitro.
To ask if endogenous ElrA binds the cyclin E1 30UTR,
we immunoprecipitated protein–RNA complexes with
antibody raised against human HuR or Xenopus ElrA
(13). Radiolabeled cyclin E1 or cyclin A1 30UTR was
microinjected into 2-h (2 cell) embryos and protein
extracts were prepared at 4 or 8h. Protein extracts were
UV-cross-linked and then immunoprecipitated with anti-
HuR, anti-ElrA or pre-immune serum. Both antibodies
immunoprecipitated RNA–protein complexes with
the cyclin E1 but not the cyclin A1 30UTR (Figure 2),
showing that endogenous ElrA associates speciﬁcally with
the 30UTR of cyclin E1 both before and after the MBT.
ElrA binds the distal partof thecyclin E130UTR
Since the distal part of the cyclin E1 30UTR contains an
ARE and a potential CPE, we next asked if ElrA binds
this region. The cyclin E1 30UTR sequence with these
regions indicated is shown in Supplementary Figure S1.
We deleted either the distal (i1575–1784) or the proximal
(i1387–1571) part of the cyclin E1 30UTR (Figure 3A)
Figure 3. ElrA binds the distal portion of the cyclin E1 30UTR. (A) Schematic of 30UTR deletions. E1 is the full-length 30UTR of cyclin E1 mRNA
with nucleotides (numbers), restriction sites (E-EcoRI, A-AvaI, EV-EcoRV) and the relative positions of the cis-elements indicated (ARE, AU-rich
element; CPE, cytoplasmic polyadenylation element; NPS, nuclear polyadenylation sequence). i1575-1784 has the distal part of the 30UTR deleted
while 1387-1571 has the proximal part deleted. Phosphorimages of UV-cross-link assays of GST-ElrA with (B) i1575-1784 or (C) 1387-1571 are
shown. The indicated radiolabeled RNA was incubated with GST-ElrA, GST or 4- and 8-h embryo extracts. RNase T1 lane is the RNA digested
with this enzyme in the absence of added protein. Molecular weight markers are indicated to the left in kDa. The arrow indicates a 36-kDa protein
that binds in embryo extracts. n¼3.
Figure 2. Endogenous ElrA binds the 30UTR of cyclin E1 mRNA.
Radiolabeled cyclin E1 30UTR or cyclin A1 30UTR was microinjected
into two cell-embryos between 1.5 and 2h post-fertilization (hpf) and
time points were taken at 4 and 8h. Protein extracts were prepared,
treated with RNase T1, and UV-cross-linked to preserve RNA–protein
complexes. Cross-linked embryo extracts were immunoprecipitated with
either anti-HuR, anti-ElrA or pre-immune serum as described in the
materials and methods section. Phosphorimages of the immunopreci-
pitated RNA–protein complexes are shown. Molecular weight markers
are indicated to the right in kDa. n¼3.
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link analyses (Figure 3B and C). ElrA did not bind the
proximal part of the cyclin E1 30UTR (Figure 3B).
In contrast, ElrA bound the distal part equally as well
as it bound the full-length 30UTR (compare Figure 3C
and 1A). Similarly, the distal part of the cyclin E1 30UTR
bound the 36-kDa protein similar to the full-length
30UTR (Figure 3C, lanes labeled 4 and 8), whereas there
were no detectable proteins bound to the proximal part
(Figure 3B).
Consistent with these results, the ARE is predicted by
mfold analysis (22) to participate in a stem loop similar
to one forming an HuR target site (Figure 4B, region 1;
(23)). The U15 CPE ﬁts the consensus sequence for an
embryonic CPE that has been shown to bind ElrA (12)
and also conforms to a nine-nucleotide consensus motif
(NNUUNNUUU) reported as a single-stranded binding
site for HuR (Figure 4B, region 2; (24)). Similar structures
or sequences are also present in the distal part of the
30UTR of Xenopus tropicalis cyclin E1 mRNA (Figure 4A,
regions 1 and 2). The X. tropicalis structure (Figure 4A,
region 1) is more GC rich, but similarly contains an 8-nt
loop. The remaining six uridines of the X. laevis CPE and
the NPS form a stem with upstream sequence (Figure 4B,
region 3), as does the equivalent sequence in X. tropicalis,
a ﬁve uridine stretch followed by the NPS (Figure 4A,
region 3). Lastly, a region of sequence similarity
following the NPS forms a stem loop in both species
(Figure 4A and B, region 4).
The distal region of thecyclin E130UTR specifies
polyadenylation
Previously we showed that when placed downstream of a
heterologous ORF and 50UTR (that of globin) the cyclin
E1 30UTR conferred stable polyadenylation on a chimeric
mRNA. We asked if ElrA binding might play a role in this
polyadenylation. We tested this possibility, using in vitro
synthesized, m
7G-capped reporter RNAs consisting
only of the full-length cyclin E1 30UTR (E1) or deletion
mutants 1387–1571 and 1575–1784, to ask if the distal
region of the 30UTR that binds ElrA directs polyadenyla-
tion. E1 and 1387–1571 became polyadenylated soon
after injection into fertilized embryos, as evidenced by
a decrease in gel mobility (Figure 5A and C). In contrast,
1575–1784 was not polyadenylated and was unstable,
as the gel mobility did not change and the signal decreased
rapidly after injection (Figure 5B).
To identify which region of the distal 30UTR was
responsible for polyadenylation, we created several
smaller deletions within the context of the complete
30UTR (Figure 6A). The NPS was ﬁrst deleted as it
has been reported to be required for CPE-mediated
Figure 4. Cyclin E1 30UTR structure as predicted by the mfold algorithm (22). The entire 30UTR of either X. tropicalis (A, Genbank accession
NM_001016328) or X. laevis (B, Genbank accession Z13966) was folded using the mfold algorithm. The most stable predicted structure is shown,
along with its free-energy value (dG) as compared to the initial free energy before folding. Only the distal part of the 30UTR is shown due to space
limitations (X. laevis nt 1641–1784, X. tropicalis nt 1617–1861). Large numbers show similar sequences and/or structures between the species as
explained in the text. Small numbers refer to nucleotides with the ﬁrst nucleotide of the 30UTR set as 1.
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occurred in the absence of the NPS but with slower
kinetics and a shorter poly(A) tail (Figure 6C) when
compared to the full-length 30UTR (Figure 6B). Deletion
of both the NPS and the contiguous CPE resulted in
a polyadenylation pattern similar to deletion of the
NPS alone, except that more of the RNA remained
unadenylated for longer (Figure 6D). Polyadenylation
in the absence of these elements indicated that additional
cis-acting element(s) were present. Deletion of the
upstream ARE very slightly aﬀected polyadenylation,
with some unadenylated RNA remaining at 4 and 6hpf
(Figure 6E). In contrast, a deletion beginning 36-nt
upstream of the ARE and continuing through the CPE
completely abolished polyadenylation and destabilized
the RNA (Figure 6F). A more limited deletion of these
36nt and the ARE (i1648-1712) has an identical
adenylation pattern (data not shown) suggesting that the
upstream sequence, which is U-rich, is also important
for polyadenylation and mRNA stability (see Figures 4B
and S1, for the cyclin E1 30UTR sequence). Similarly,
deleting from the ARE through the NPS abolished
polyadenylation and destabilized the RNA (Figure 6G).
A summary of the eﬀects of the deletions on mRNA
stability over several experiments is shown in Figure 6H.
All deletions decreased stability of the mRNA, with
simultaneous deletion of the ARE, CPE and NPS having
the most dramatic eﬀect. Taken together, these data
strongly indicate that the ARE, CPE and NPS are all
required for the proper polyadenylation and stabilization
of cyclin E1 mRNA.
We next determined how deletion of these regions of the
30UTR inﬂuenced ElrA binding. Deletion of both the CPE
and NPS increased the Kd of ElrA for the cyclin E1 30UTR
5-fold from 1 to 5nM (Figure 7A), while a similar 7-fold
increase was seen when either the ARE (Figure 7B) or
NPS (data not shown) was deleted alone. When the ARE,
CPE and the NPS were deleted the Kd increased to 29nM,
approximately another 5-fold (Figure 7C). These results
indicate that ElrA binds similarly to the CPE/NPS and
the ARE. Eﬃcient binding requires all of these regions.
The dramatic reduction in both polyadenylation and
ElrA binding by deletion of these sequences provides
compelling evidence that ElrA inﬂuences both the poly-
adenylation and stability of the cyclin E1 mRNA.
DISCUSSION
These studies demonstrate that ElrA binds to the 30UTR
of cyclin E1 mRNA and that the region required for its
binding functions in the polyadenylation and stabiliza-
tion of the mRNA. ELAV was initially reported as an
RNA binding protein whose presence was critical for
neuronal development in Drosophila (27,28). Additional
members of the ELAV family of proteins have been
identiﬁed in several species and demonstrate a high degree
of conservation (13,29). ELAV members play a role
in post-transcriptional regulation with functions that
include mRNA splicing, localization and stabilization
(30–34). Our data implicate a function for ElrA in both
cytoplasmic polyadenylation and mRNA stabilization.
It was previously reported that ElrA bound to two
diﬀerent maternal mRNAs in X. laevis embryos, Cl2 and
the activin receptor mRNAs, in a manner dependent on
the presence of their embryonic-speciﬁc CPEs (12).
In contrast, ElrA did not bind to the histone B4 mRNA
that contains a maturation-speciﬁc CPE. The embryonic
CPE consensus sequence is oligo U12–27 and it functions at
a range of 10–271nt upstream of the NPS, while the
maturation CPE consensus is U5AU and it functions from
100-nt upstream, contiguous with, or even downstream of
the NPS (35). We report here, for the ﬁrst time, that ElrA
binds a maturation CPE simultaneously with an ARE in
the cyclin E1 30UTR. The CPE (U15A2U) in the cyclin E1
30UTR meets both the location and sequence requirements
for a maturation-type CPE. Contrarily, the cyclin
A1 30UTR does not bind ElrA (Figures 1B and 2) despite
containing 2 AREs (U2AU3AU2) and a maturation-type
CPE that functions in both oocytes and embryos
(7,36). The cyclin A1 CPE sequence is identical to that
of histone B4 (U5A2U) (12). It is likely that the additional
10 uridines in the cyclin E1 CPE contribute to stable ElrA
binding. The ARE in the cyclin E1 30UTR loosely meets
the requirements for an embryonic CPE, located 45-nt
Figure 5. The distal portion of the 30UTR of cyclin E1 mRNA speciﬁes polyadenylation. Radiolabeled cyclin E1 30UTR (A)o r3 0UTR deletions
(B) i1575-1784 or (C) 1387-1571 were injected into two cell-embryos. Total RNA was extracted at the indicated hour post-fertilization (hpf),
electrophoresed on a denaturing gel and analyzed by phosphorimaging. U is RNA before injection. Nucleotide markers are indicated on the left.
Bracket indicates polyadenylated RNA. The 2-hpf sample was taken 5min post-injection. n¼5.
2172 Nucleic Acids Research, 2007, Vol. 35, No. 7Figure 6. Polyadenylation requires a minimum of three cis-elements in the 30UTR. (A) Schematic of 30UTR deletion mutants used in panels (B–G).
The names of the RNAs and the nucleotides deleted are indicated on the right. E1 is the full-length cyclin E1 30UTR as described in Figure 3. (B–G)
show polyadenylation assays for the 30UTR deletion mutants indicated performed as described in Figure 3. U is RNA before injection. Nucleotide
markers are indicated on the left. Bracket indicates polyadenylated RNA. The 2-hpf sample was taken 5-min post-injection. n¼2 for panel E; n¼3
for panels C, D and F; n¼4 for panels A and G. (H) Graph showing the percent of indicated RNA remaining (þ/  SEM) at each timepoint
averaged over all experiments. Quantitation was performed with Imagequant (Molecular Dynamics).
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U5AU5AU6. In comparison, the Cl2 embryonic CPE
(U16GU4GU4) is 34-nt upstream of the NPS, while the
activin receptor CPE is two U14 sequences separated by
42-nt and 164-nt upstream of the NPS. Regardless of
the label given to them, ElrA binding to the cyclin E1
30UTR requires the presence of these two U-rich regions
that function in mRNA polyadenylation and stabilization.
The 30UTR of cyclin E1 directed polyadenylation
independent of translation, as an RNA consisting only
of the 30UTR or its distal end was polyadenylated identi-
cally to the endogenous mRNA or a chimeric mRNA
containing the cyclin E1 30UTR (this article and 7).
Of particular interest was the observation that deletion of
the NPS, either alone or in association with the potential
CPE, slowed but did not abolish polyadenylation.
In polyadenylation directed by maturation-type CPEs,
the NPS serves as a binding site for CPSF and its
associated polyadenylation factors, including poly(A)
polymerase. Our data show that a sequence in the cyclin
E1 30UTR directs polyadenylation independently of the
NPS and CPE, rare for all known cytoplasmic poly-
adenylation reactions. Deletion of the ARE alone did not
disrupt polyadenylation, but additional deletion of the
upstream 36nt did. An example of non-CPE directed
polyadenylation is the cytosine-rich sequence important
for polyadenylation of protein phosphatase 2A (37),
but the sequence upstream of the ARE in the cyclin
E1 30UTR is not cytosine-rich. It is possible that the
upstream region is needed to stabilize ElrA binding to the
ARE or for binding of other proteins that may interact
with ElrA. The combined action of these elements is most
likely responsible for the continued polyadenylation and
stability of the cyclin E1 mRNA following the MBT,
when many other maternal mRNAs are deadenylated
and destabilized. Interestingly, mfold analysis shows that
in the most stable predicted structure, these upstream
nucleotides form a stem by base pairing with the NPS
(Figure 4B). These sequences and/or structures are
roughly conserved in X. tropicalis cyclin E1 30UTR
(Figure 4A), suggesting that function is also conserved.
We are currently testing this hypothesis.
ElrA binding these elements may either support the
assembly of the cytoplasmic polyadenylation machinery
or maintain polyadenylation of the cyclin E1 mRNA
once it is attained. ElrA associates with the cyclin E1
30UTR independently of its adenylation state, consistent
with either of these potential roles. ElrA has been shown
to protect the body of deadenylated mRNA from
degradation in vitro, in association with the Xenopus
cold-inducible RNA-BP (xCIRP) (38). As the cyclin
E1 mRNA remains stably polyadenylated past the MBT,
it is obviously not protecting the deadenylated mRNA
body from degradation. Consistent with a role for ElrA
in regulating cyclin E1 mRNA, we have recently shown
that its human homolog, HuR, binds to and stabilizes the
mRNA encoding human cyclin E1 (39). The sequences/
structures that HuR binds in the human cyclin E1 30UTR
are currently being mapped.
Despite ElrA association and maintenance of poly-
adenylation past the MBT, cyclin E1 mRNA is translated
eﬀectively only during oocyte maturation and the ﬁrst two
cell cycles following fertilization (3). Cyclin E1 transla-
tion drops dramatically following the second cell cycle
(6) followed by the terminal disappearance of the protein
at the MBT (3,4,8). Overexpression of cyclin E1 before
the MBT results in embryonic death (40). These studies
suggest that tight regulation of the translational eﬃciency
of cyclin E1 is critical for embryogenesis. How is cyclin E1
translationally repressed in early embryos? A translational
Figure 7. Deletion of the 30UTR cis-elements disrupts ElrA binding. Here, 1fmol of the indicated radiolabeled RNA was incubated with GST-ElrA
over a range of 0–50nM. Reactions were electrophoresed on native gels, phosphorimaged (top panels) and the results quantitated (bottom panels).
Bound and free RNA are indicated by the lines on the right. n¼2 for panels (A and B), n¼3 for panel (C).
2174 Nucleic Acids Research, 2007, Vol. 35, No. 7repressor may bind the cyclin E1 mRNA following
translation during cell cycles 1 and 2. The binding of
both ElrA and a translational repressor would explain
how cyclin E1 remains polyadenylated and is translation-
ally repressed following the second cell cycle.
Alternatively, ElrA may be involved in both polyadenyla-
tion and translational repression of cyclin E1. HuR has
been shown to function in translational repression (41)
and the ELAV family member ElrB binds to and
translationally represses the maternal Vg1 mRNA
during Xenopus oocyte maturation (42). ElrA is present
in oocytes presenting the possibility that it associates with
cyclin E1 mRNA during oocyte maturation to facilitate
polyadenylation and/or translation. One scenario is that
following fertilization, ElrA either associates with diﬀerent
protein partners or is post-translationally modiﬁed chan-
ging its function to a repressor of translation. We are at
present investigating this possibility.
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